First Time Loading...
H

HLB Life Science Co Ltd
KOSDAQ:067630

Watchlist Manager
HLB Life Science Co Ltd
KOSDAQ:067630
Watchlist
Price: 15 770 KRW -4.13%
Updated: May 10, 2024

Intrinsic Value

HLB Life Sciences Co., Ltd. engages in the provision of energy saving services. [ Read More ]

The intrinsic value of one HLB Life Science Co Ltd stock under the Base Case scenario is 2 712.67 KRW. Compared to the current market price of 15 770 KRW, HLB Life Science Co Ltd is Overvalued by 83%.

Key Points:
Intrinsic Value
Base Case
2 712.67 KRW
Overvaluation 83%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation Backtest
HLB Life Science Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling HLB Life Science Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
HLB Life Science Co Ltd

Provide an overview of the primary business activities
of HLB Life Science Co Ltd.

What unique competitive advantages
does HLB Life Science Co Ltd hold over its rivals?

What risks and challenges
does HLB Life Science Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for HLB Life Science Co Ltd.

Provide P/S
for HLB Life Science Co Ltd.

Provide P/E
for HLB Life Science Co Ltd.

Provide P/OCF
for HLB Life Science Co Ltd.

Provide P/FCFE
for HLB Life Science Co Ltd.

Provide P/B
for HLB Life Science Co Ltd.

Provide EV/S
for HLB Life Science Co Ltd.

Provide EV/GP
for HLB Life Science Co Ltd.

Provide EV/EBITDA
for HLB Life Science Co Ltd.

Provide EV/EBIT
for HLB Life Science Co Ltd.

Provide EV/OCF
for HLB Life Science Co Ltd.

Provide EV/FCFF
for HLB Life Science Co Ltd.

Provide EV/IC
for HLB Life Science Co Ltd.

Compare the intrinsic valuations
of HLB Life Science Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of HLB Life Science Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of HLB Life Science Co Ltd compared to its peers.

Compare the P/E ratios
of HLB Life Science Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing HLB Life Science Co Ltd with its peers.

Analyze the financial leverage
of HLB Life Science Co Ltd compared to its main competitors.

Show all profitability ratios
for HLB Life Science Co Ltd.

Provide ROE
for HLB Life Science Co Ltd.

Provide ROA
for HLB Life Science Co Ltd.

Provide ROIC
for HLB Life Science Co Ltd.

Provide ROCE
for HLB Life Science Co Ltd.

Provide Gross Margin
for HLB Life Science Co Ltd.

Provide Operating Margin
for HLB Life Science Co Ltd.

Provide Net Margin
for HLB Life Science Co Ltd.

Provide FCF Margin
for HLB Life Science Co Ltd.

Show all solvency ratios
for HLB Life Science Co Ltd.

Provide D/E Ratio
for HLB Life Science Co Ltd.

Provide D/A Ratio
for HLB Life Science Co Ltd.

Provide Interest Coverage Ratio
for HLB Life Science Co Ltd.

Provide Altman Z-Score Ratio
for HLB Life Science Co Ltd.

Provide Quick Ratio
for HLB Life Science Co Ltd.

Provide Current Ratio
for HLB Life Science Co Ltd.

Provide Cash Ratio
for HLB Life Science Co Ltd.

What is the historical Revenue growth
over the last 5 years for HLB Life Science Co Ltd?

What is the historical Net Income growth
over the last 5 years for HLB Life Science Co Ltd?

What is the current Free Cash Flow
of HLB Life Science Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for HLB Life Science Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
HLB Life Science Co Ltd

Current Assets 147B
Cash & Short-Term Investments 77.7B
Receivables 14.6B
Other Current Assets 54.7B
Non-Current Assets 276.5B
Long-Term Investments 147.2B
PP&E 72.9B
Intangibles 55.8B
Other Non-Current Assets 554.7m
Current Liabilities 135.5B
Accounts Payable 5.2B
Accrued Liabilities 2.3B
Short-Term Debt 10.2B
Other Current Liabilities 117.8B
Non-Current Liabilities 57.2B
Long-Term Debt 51.8B
Other Non-Current Liabilities 5.4B
Efficiency

Earnings Waterfall
HLB Life Science Co Ltd

Revenue
98B KRW
Cost of Revenue
-98.7B KRW
Gross Profit
-748.6m KRW
Operating Expenses
-23.8B KRW
Operating Income
-24.5B KRW
Other Expenses
18.5B KRW
Net Income
-6B KRW

Free Cash Flow Analysis
HLB Life Science Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

HLB Life Science Co Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Positive 3-Years Revenue Growth
Negative 1-Year Revenue Growth
Declining ROIC
25/100
Profitability
Score

HLB Life Science Co Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

HLB Life Science Co Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
51/100
Solvency
Score

HLB Life Science Co Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
HLB Life Science Co Ltd

There are no price targets for HLB Life Science Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
HLB Life Science Co Ltd

1M 1M
-2%
6M 6M
+73%
1Y 1Y
+37%
3Y 3Y
+56%
5Y 5Y
+111%
10Y 10Y
+2 326%
Annual Price Range
15 770
52w Low
8 380
52w High
24 300
Price Metrics
Average Annual Return 13.82%
Standard Deviation of Annual Returns 44.9%
Max Drawdown -65%
Shares Statistics
Market Capitalization 1.6T KRW
Shares Outstanding 107 552 080
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

HLB Life Science Co Ltd

Country

Korea

Industry

Health Care

Market Cap

1.6T KRW

Dividend Yield

0%

Description

HLB Life Sciences Co., Ltd. engages in the provision of energy saving services. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2008-11-25. Along with subsidiaries, the Company operates its business through four segments. The Pharmaceutical Distribution segment is involved in the sale of pharmaceuticals and raw materials through SHINWHAADVANCE.CO.LTD. The Energy Business segment is engaged in energy service company (ESCO) business. The company is equipped with equipments, assets and technical personnel to engage in energy saving investment business. The Bio Development segment is engaged in the development of extracorporeal circulation type bio space, hepatocyte treatment agents and hemostatic agents. The main products include anticancer drugs such as Tegatrabetan and Seclidemstat. The Other Business segment is involved in the investment of small business start-ups and venture businesses, as well as manufacturing and sale of light emitting diode (LED) products.

Contact

GYEONGGI-DO
Hwaseong
8F, M Tower Knowledge Industry Center, 51-9, Dongtancheomdansaneop 1-ro
+82226276700
http://www.hlb-ls.com/

IPO

2008-11-25

Employees

-

Officers

Chief Exec. Officer and Pres
Sung-Bo Sim

See Also

Discover More
What is the Intrinsic Value of one HLB Life Science Co Ltd stock?

The intrinsic value of one HLB Life Science Co Ltd stock under the Base Case scenario is 2 712.67 KRW.

Is HLB Life Science Co Ltd stock undervalued or overvalued?

Compared to the current market price of 15 770 KRW, HLB Life Science Co Ltd is Overvalued by 83%.